158 related articles for article (PubMed ID: 8399646)
1. Procollagen type-I in the serum and dialysate of continuous ambulatory peritoneal dialysis patients.
Digenis GE; Dombros NV; Christophoraki M; Grapsa I; Savidis N; Datseris J; Samuilidou E; Zerefos N; Tourkantonis A
Perit Dial Int; 1993; 13 Suppl 2():S480-3. PubMed ID: 8399646
[TBL] [Abstract][Full Text] [Related]
2. Type I procollagen propeptide in patients on CAPD: its relationships with bone histology, osteocalcin, and parathyroid hormone.
Joffe P; Heaf JG; Jensen LT
Nephrol Dial Transplant; 1995 Oct; 10(10):1912-7. PubMed ID: 8592603
[TBL] [Abstract][Full Text] [Related]
3. Type I and III procollagens in CAPD: markers of peritoneal fibrosis.
Joffe P; Jensen LT
Adv Perit Dial; 1991; 7():158-60. PubMed ID: 1680415
[TBL] [Abstract][Full Text] [Related]
4. Relationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysate.
Cho MS; Lee KS; Lee YK; Ma SK; Ko JH; Kim SW; Kim NH; Choi KC
Korean J Intern Med; 2002 Jun; 17(2):114-21. PubMed ID: 12164088
[TBL] [Abstract][Full Text] [Related]
5. Procollagen-I and collagen-I in the serum and dialysate of CAPD patients: changes over time.
Digenis GE; Dombros NV; Balaskas EV; Christophoraki M; Kontessis P; Papantoniou V; Zerefos N; Tourkantonis A
Perit Dial Int; 1995; 15(8):371-4. PubMed ID: 8785239
[No Abstract] [Full Text] [Related]
6. Dialysate markers of peritoneal tissue during peritonitis and in stable CAPD.
Pannekeet MM; Zemel D; Koomen GC; Struijk DG; Krediet RT
Perit Dial Int; 1995; 15(6):217-25. PubMed ID: 7578497
[TBL] [Abstract][Full Text] [Related]
7. [Type III procollagen N-peptide and hyaluronate in serum and dialysate of CAPD patients].
Wakabayashi Y; Yamada K; Miura Y; Nakano H; Nishimura M; Tsuchida H; Shigematsu T; Kawaguchi Y; Sakai O
Nihon Jinzo Gakkai Shi; 1997 May; 39(4):408-13. PubMed ID: 9198363
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of carboxy-terminal propeptide of type I procollagen in pediatric patients undergoing peritoneal dialysis.
Leszczynska B; Roszkowska-Blaim M
Adv Perit Dial; 2002; 18():2-5. PubMed ID: 12402576
[TBL] [Abstract][Full Text] [Related]
9. Low dialysate calcium in continuous ambulatory peritoneal dialysis: a randomized controlled multicenter trial. The Peritoneal Dialysis Multicenter Study Group.
Weinreich T; Passlick-Deetjen J; Ritz E
Am J Kidney Dis; 1995 Mar; 25(3):452-60. PubMed ID: 7872324
[TBL] [Abstract][Full Text] [Related]
10. PICP as bone formation and NTx as bone resorption marker in patients with chronic renal failure.
Franke S; Lehmann G; Abendroth K; Hein G; Stein G
Eur J Med Res; 1998 Feb; 3(1-2):81-8. PubMed ID: 9512973
[TBL] [Abstract][Full Text] [Related]
11. Serum concentration of the aminopropeptide of type I procollagen in patients on haemo- and peritoneal dialysis.
Jensen PB; Rasmussen HB; Pedersen FB
APMIS; 1997 May; 105(5):371-7. PubMed ID: 9201238
[TBL] [Abstract][Full Text] [Related]
12. Serum procollagen type I carboxyterminal propeptide in CAPD and hemodialysis patients.
Gerakis A; Apostolou T; Bagiatoudi G; Tzouganatou A; Margellos V; Nikolopoulou N; Billis A
Perit Dial Int; 1996; 16 Suppl 1():S309-11. PubMed ID: 8728213
[No Abstract] [Full Text] [Related]
13. Clinical usefulness of serum carboxyterminal propeptide of procollagen I and tartrate-resistant acid phosphatase determinations to evaluate bone turnover in patients with chronic renal failure.
López Gavilanes E; González Parra E; de la Piedra C; Caramelo C; Rapado A
Miner Electrolyte Metab; 1994; 20(5):259-64. PubMed ID: 7700213
[TBL] [Abstract][Full Text] [Related]
14. Long-term dialysis with low-calcium solution (1.0 mmol/L) in CAPD: effects on bone mineral metabolism. Collaborators of the Multicenter Study Group.
Weinreich T; Ritz E; Passlick-Deetjen J
Perit Dial Int; 1996; 16(3):260-8. PubMed ID: 8761540
[TBL] [Abstract][Full Text] [Related]
15. Serum magnesium concentration is an independent predictor of parathyroid hormone levels in peritoneal dialysis patients.
Navarro JF; Mora C; Macia M; Garcia J
Perit Dial Int; 1999; 19(5):455-61. PubMed ID: 11379859
[TBL] [Abstract][Full Text] [Related]
16. Leptin in peritoneal dialysate from continuous ambulatory peritoneal dialysis patients.
Tsujimoto Y; Shoji T; Tabata T; Morita A; Emoto M; Nishizawa Y; Morii H
Am J Kidney Dis; 1999 Nov; 34(5):832-8. PubMed ID: 10561138
[TBL] [Abstract][Full Text] [Related]
17. Does low-calcium dialysate accelerate secondary hyperparathyroidism in continuous ambulatory peritoneal dialysis patients?
Rotellar C; Kinsel V; Goggins M; Tarman G; Stull M; Mazzoni MJ; Mosher WF; Rakowski TA; Winchester JF
Perit Dial Int; 1993; 13 Suppl 2():S471-2. PubMed ID: 8399643
[TBL] [Abstract][Full Text] [Related]
18. Low calcium (1.25 mmol/L) dialysate can normalize relative hypoparathyroidism in CAPD patients with low bone turnover.
Shigematsu T; Kawaguchi Y; Kubo H; Nakayama M; Kato N; Yamamoto H; Osaka N; Hayakawa H; Ogawa A; Sakai O
Adv Perit Dial; 1996; 12():250-6. PubMed ID: 8865914
[TBL] [Abstract][Full Text] [Related]
19. Biochemical markers of bone turnover in the diagnosis of renal osteodystrophy in dialyzed children.
Baskin E; Beşbaş N; Saatçi U; Hasçelik G; Topaloğlu R; Ozen S; Bakkaloğlu A
Turk J Pediatr; 2004; 46(1):28-31. PubMed ID: 15074371
[TBL] [Abstract][Full Text] [Related]
20. Comparative study between intact PTH and fragments of PTH in patients on hemodialysis and CAPD.
Martinez M; Ausejo M; Miguel JL; Gonzalez ML; Balaguer G; Catalan P; Selgas R
Perit Dial Int; 1991; 11(2):137-40. PubMed ID: 1854870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
